Cyclacel is ranked 565,525 in the United Kingdom. 'Cyclacel Pharmaceuticals, Inc. | Biopharmaceutical company developing cell cycle control cancer therapies.'
565,525Rank in United Kingdom
7,321,661Worldwide Rank
| Monthly pages viewed | 6,804 | |
| Monthly visits | 1,425 | |
| Value per visitor | £0.04 | |
| Estimated worth | £862.51 | |
| External links | 170 | |
| Number of pages | 3,525 |
Last Updated: 05/04/2018 . Estimated data, read disclaimer.
Visitors
| Traffic History 90 Day Average | ||
| Worldwide Rank | 6,152,656 |  2,778,164 |
|---|---|---|
| Daily Visitors | 30 | -51.35% |
| Daily Visitors Rank | 6,458,403 | 2,598,309 |
| Daily Pageviews | 0 | -70.91% |
| Daily Pageviews Rank | 6,266,992 | 3,332,180 |
| Pageviews Per User | 2.20 | -40.21% |
www.Cyclacel.com
Topics: Research And Development Pipeline, People, Management Team, Board Of Directors, Scientific Advisory Team, and Alliances And Collaborations.
Age: It went live on September 4th 1997, making it over 20 years, 7 months old.
- Popular pages
- cyclacel.com Cyclacel Pharmaceuticals, Inc. - A biopharmaceutical company ..
- cyclacel.com Impact of DNA repair proteins on cell survival in response to ..
- cyclacel.com A novel, orally available, targeted CDK inhibitor in development ..
- cyclacel.com Pharmacodynamic Effects of Seliciclib, an Orally Administered Cell ..
On average 2.20 pages are viewed each, by the estimated 33 daily visitors.
Links- Links in
- cancertechnology.co.uk Cancer Research Technology Ltd | CRT
- excaliburfundmanagers... Excalibur Fund Managers
- px-therapeutics.com PX'Therapeutics : Therapeutic proteins, recombinant proteins
- biopharmconsortium.com Biotechnology Consulting, Pharmaceutical Consulting- Haberman
- Links out
- cancerresearchuk.org Cancer Research UK: the UK's leading cancer charity
- fda.gov U S Food and Drug Administration Home Page
- sec.gov U.S. Securities and Exchange Commission (Home Page)
- pnas.org Proceedings of the National Academy of Sciences
| Server Location | |
| Keybridge Corporation Customer England Brighton United Kingdom 50.83, -0.15 | |
ASP.NET is its coding language environment. ns2.dreamhost.com, ns3.dreamhost.com, and ns1.dreamhost.com are its DNS Nameservers. It is hosted by Keybridge Corporation Customer (England, Brighton,) using Microsoft-IIS/6 web server.
IP: 195.149.127.10
Powered by: ASP.NET
Web Server: Microsoft-IIS/6
Encoding: iso-8859-1
| PING production.investis.com (195.149.127.10) 56(84) bytes of data. | |
| From ns3.investis.com (213.199.33.45) icmp_seq=1 Time to live exceeded | |
| From ns3.investis.com (213.199.33.45) icmp_seq=2 Time to live exceeded | |
| From ns3.investis.com (213.199.33.45) icmp_seq=3 Time to live exceeded | |
| --- production.investis.com ping statistics --- | |
| 3 packets transmitted, 0 received, +3 errors, 100% packet loss, time 2003ms | |
| Server Setup | |
| Date: | -- |
|---|---|
| Server: | Microsoft-IIS/6.0 |
| X-Powered-By: | ASP.NET |
| X-Powered-By: | PleskWin |
| Content-Length: | 18921 |
| Content-Type: | text/html |